Dissemin is shutting down on January 1st, 2025

Published in

American Diabetes Association, Diabetes, 2(61), p. 281-291, 2012

DOI: 10.2337/db11-0649

Links

Tools

Export citation

Search in Google Scholar

Thel-α-Lysophosphatidylinositol/GPR55System and Its Potential Role in Human Obesity

Journal article published in 2012 by José María Moreno-Navarrete ORCID, Victoria Catalán, Lauren Whyte, Adenis Díaz-Arteaga, Rafael Vázquez-Martínez, Fernando Rotellar, Rocío Guzmán, Javier Gómez-Ambrosi, Marina R. Pulido, Wendy R. Russell, Mónica Imbernón, Ruth A. Ross, María M. Malagón ORCID, Carlos Dieguez, José Manuel Fernández-Real and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

GPR55 is a putative cannabinoid receptor, and l-α-lysophosphatidylinositol (LPI) is its only known endogenous ligand. We investigated 1) whether GPR55 is expressed in fat and liver; 2) the correlation of both GPR55 and LPI with several metabolic parameters; and 3) the actions of LPI on human adipocytes. We analyzed CB1, CB2, and GPR55 gene expression and circulating LPI levels in two independent cohorts of obese and lean subjects, with both normal or impaired glucose tolerance and type 2 diabetes. Ex vivo experiments were used to measure intracellular calcium and lipid accumulation. GPR55 levels were augmented in the adipose tissue of obese subjects and further so in obese patients with type 2 diabetes when compared with nonobese subjects. Visceral adipose tissue GPR55 correlated positively with weight, BMI, and percent fat mass, particularly in women. Hepatic GPR55 gene expression was similar in obese and type 2 diabetic subjects. Circulating LPI levels were increased in obese patients and correlated with fat percentage and BMI in women. LPI increased the expression of lipogenic genes in visceral adipose tissue explants and intracellular calcium in differentiated visceral adipocytes. These findings indicate that the LPI/GPR55 system is positively associated with obesity in humans.